The opioid crisis is fueling a dramatic increase in infectious diseases, particularly bloodborne infections, associated with injection drug use. The recent threefold increase in hepatitis C, the 2015 HIV outbreak in Indiana, the ongoing outbreaks of acute hepatitis A virus among persons experiencing homelessness and persons who inject drugs, and a 238% increase in endocarditis hospitalizations in a 13-year period are powerful evidence that persons who inject drugs are at high risk for infectious disease. To prevent and halt the effects of the co-occurring epidemics, a comprehensive approach is needed that includes: stopping outbreaks of preventable communicable disease and supporting comprehensive syringe service programs as a pathway to prevention by linking people to medication assisted therapy for substance use and infectious disease treatment.
This session is accredited for the following accreditation types: CME, CNE, CPE, APA, AAFP, AAHCPAD*, NAADAC*, ASWB*
*State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.